Sumitomo Mitsui Trust Holdings, Inc. Corcept Therapeutics Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,899 shares of CORT stock, worth $205,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,899Holding current value
$205,684% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CORT
# of Institutions
418Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.17 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$718 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$575 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$440 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$282 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.6B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...